TRMED.OL Thor Medical ASA
- Market cap
- NOK 1.74B
- P/E
- -
- P/B
- 4.06x
- ROE
- -12.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is TRMED.OL undervalued?
Graham numberThe Graham number of Thor Medical ASA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Thor Medical ASA fundamental analysis
No fundamental analysis for Thor Medical ASA yet.
Thor Medical ASA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Full company profileThor Medical ASA financial statements
Thor Medical ASA annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 439K |
| Gross Profit | -14.9M | -11.4M | - | -331K | -2.38M | - |
| Operating Income | -442M | -448M | -317M | -7.34M | -52.7M | -69.7M |
| EBITDA | -401M | -428M | 11.2M | -6.83M | -41.6K | -40.7M |
| Net Income | -417M | -441M | -311M | -26.6M | -42.2M | -58.0M |
| EPS | -5.92 | -4.65 | -2.70 | -0.15 | -0.18 | -0.16 |
| Balance Sheet | ||||||
| Total Assets | 315M | 297M | 110M | 331M | 414M | 709M |
| Total Liabilities | 136M | 156M | 45.8M | 58.9M | 77.3M | 253M |
| Shareholders' Equity | 179M | 141M | 63.8M | 272M | 337M | 456M |
| Cash & Short-term Investments | 293M | 277M | 96.6M | 41.3M | 123M | 179M |
| Total Debt | 4.57M | 5.51M | 159K | - | 737K | - |
| Cash Flow | ||||||
| Operating Cash Flow | -398M | -403M | -409M | -64.1M | -23.7M | -47.5M |
| Capital Expenditure | 185K | 259K | 5.63M | 0.00 | 100K | 73.1M |
| Free Cash Flow | -398M | -404M | -415M | -64.1M | -23.8M | -121M |
| Ratios | ||||||
| ROE | -233.4% | -314.1% | -487.5% | -9.8% | -12.5% | -12.7% |
| ROA | -132.6% | -148.8% | -283.9% | -8.0% | -10.2% | -8.2% |
| Net Profit Margin | - | - | - | - | - | -13,214.8% |
| Debt to Equity | 0.03x | 0.04x | 0.00x | - | 0.00x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Thor Medical ASA dividends
Thor Medical ASA has not paid dividends in the last 7 fiscal years.
Who owns Thor Medical ASA
- Insiders 35.92%
- Institutions 7.27%
- Public & others 56.81%
- Shares outstanding 423M
- Free float 204M
Thor Medical ASA company profile
- Company name
- Thor Medical ASA
- Ticker
- TRMED.OL
- ISIN
- NO0010597883
- Exchange
- Oslo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 24
- Fiscal year end
- December
- Address
- Drammensveien 167, Oslo, Norway, 0277
- Phone
- 47 97 41 40 00
- Website
- thormedical.no
About Thor Medical ASA
Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It offers thorium-228, as well as radium-224 and lead-212 to radiopharmaceutical customers. The company was incorporated in 2009 and is headquartered in Oslo, Norway.
Thor Medical ASA management
6- Mr. Jasper KurthChief Executive Officer · born 1985
- Mr. Brede EllingsæterCFO & COO
- Dr. Sindre HassfjellChief Technology Officer
- Ms. Astrid LilandExecutive Vice President of HSEQ
- Mr. Mathias Nilsen ReierthHead of Communications & Corporate Affairs
- Ms. Therese KvehaugenExecutive Vice President of Human Resources